Shell Plc stock jumps 3% as buyback rolls on; oil rally sets up week ahead

Shell Plc stock jumps 3% as buyback rolls on; oil rally sets up week ahead

London, Jan 11, 2026, 21:03 (GMT) — Market closed

  • Shell revealed it purchased roughly 2.09 million shares on Friday to cancel as part of its ongoing buyback program
  • On Friday, the stock gained roughly 3% in London, buoyed by a rise in energy shares alongside climbing oil prices
  • Traders head into Monday focused on crude prices alongside Shell’s Feb. 5 earnings and dividend announcement

Shell plc reported it acquired 2.09 million shares on Jan. 9 for cancellation, according to its latest daily update on the ongoing share buyback program. The shares were bought across London and Amsterdam markets, with Merrill Lynch International handling trades within predetermined guidelines, the company said. (GlobeNewswire)

The buyback is crucial now because it’s one of the few consistent tools Shell can pull amid volatile oil headlines shaking up prices. Shell (SHEL.L) kicked off the programme in late October, pegging it at $3.5 billion split between contracts in London and the Netherlands. The goal: cut down issued share capital by cancelling the shares it buys back. Simply put, a buyback means the company uses cash to repurchase its own stock, reducing the total shares outstanding and potentially boosting per-share figures. (Shell)

Shell shares ended Friday up 3.04% at 26.40 pounds, beating the broader market gains. Despite the jump, the stock remains roughly 10% shy of its 52-week peak. Trading volume was noticeably lighter than recent averages, according to MarketWatch data. (MarketWatch)

Energy shares pushed London stocks higher on Friday, boosted by climbing oil prices. BP and Shell each gained roughly 2.2% during the session, according to a Reuters market report. The broader FTSE rally was led by miners, with Glencore surging amid rumors of a merger with Rio Tinto. (Reuters)

Brent futures climbed $1.35, or 2.18%, closing at $63.34 a barrel on Friday. U.S. WTI rose 2.35% to $59.12. “The uprising in Iran is keeping the market on edge,” said Phil Flynn, senior analyst at Price Futures Group. Ole Hansen from Saxo Bank highlighted concerns over possible supply disruptions, while Tina Teng, market strategist at Moomoo ANZ, noted the focus on how Venezuelan oil stockpiles will be sold and delivered. Reuters also pointed to rising inventories and oversupply as potential limits to any price recovery. (Reuters)

Shell’s U.S.-listed shares were last seen at $70.83 in New York late Friday, rising roughly 0.7% from their previous close.

Equity markets are closed for the weekend, so Shell’s first real test on Monday will probably come from crude prices. When oil strengthens, it usually drags the sector up, even if Shell’s only news is the steady stream of buyback announcements.

Investors are keeping an eye on the buyback pace, as it offers a steady source of market demand. However, it won’t protect against falling commodity prices or shrinking margins.

That setup can flip quickly. If oil retreats from Friday’s surge amid signals that supply is sufficient, or if risk appetite wanes, energy stocks could slide—even as buybacks continue.

Shell’s upcoming trigger is its Q4 earnings and dividend announcement on Feb. 5. The stock goes ex-dividend in London on Feb. 19, meaning it will trade without entitlement to the next payout. Investors will focus on that date for any changes to the dividend pace and new insights on cash returns. (Shell)

Stock Market Today

  • Profound Medical: Top TSX Growth Stock Poised for Rapid Expansion, Q3 Revenues Surge 87%
    February 1, 2026, 9:22 PM EST. Profound Medical (TSX:PRN), a Canadian medical device firm specializing in MRI-guided ultrasound therapies, is highlighted as the sole TSX growth stock to hold for the next three years. The company reported an 87% revenue increase in Q3 to $5.3 million, driven by expanded installations of its flagship TULSA-PRO prostate cancer treatment system. Offering incision-free, MRI-guided ablation technology, Profound's procedures have gained Medicare approval with rising insurance reimbursements. Despite a net loss of $8 million, the company improved gross margins to 74.3% and ended Q3 with $25 million cash, supporting near-term liquidity. With 70 systems installed and 93 in advanced sales stages, Profound aims for 75 installations by year-end, making it a notable small-cap growth stock in healthcare on the TSX.
Intel stock (INTC) heads into Monday after Trump post fuels 10.8% Friday surge
Previous Story

Intel stock (INTC) heads into Monday after Trump post fuels 10.8% Friday surge

Lyon drivers face Fourviere tunnel shutdowns this week — what closes and when
Next Story

Lyon drivers face Fourviere tunnel shutdowns this week — what closes and when

Go toTop